Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment: Cochrane systematic review
Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment: Cochrane systematic review
ID - 431753
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431753/all/Inhaled_short_acting_beta2_agonist_use_in_chronic_asthma:_regular_versus_as_needed_treatment:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -